Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
4
×
biotech
drug prices
life sciences
national
national blog main
national top stories
new york top stories
novartis
4
×
san francisco top stories
alzheimer's disease
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
deals
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
medicare
new york blog main
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
aduro biotech
cancer
What
drug
4
×
bio
roundup
companies
new
patients
price
acquisitions
albert
alzheimer’s
approval
approved
atrophy
biggest
biogen’s
biopharmaceutical
bourla
ceo
company
convo
crispr
daily
different
earlier
evrysdi
fail
failures
fda
friday
future
gene
green
home
imports
increases
intended
latest
lights
liquid
littered
Language
unknown
unset
Current search:
biogen
×
drug
×
novartis
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More